Effects of smoking cessation on lung function and airway inflammation in smokers with asthma.

RATIONALE Active smoking in asthma is associated with worsening of symptoms, accelerated decline in lung function, and impaired response to corticosteroids. OBJECTIVES To examine the short-term effects of smoking cessation on lung function, airway inflammation, and corticosteroid responsiveness in smokers with asthma. METHODS AND MEASUREMENTS Smokers with asthma were given the option to quit or continue smoking. Both groups underwent spirometry and induced sputum at baseline and at 1, 3, and 6 wk. Cutaneous vasoconstrictor response to topical beclometasone, airway response to oral prednisolone, and sensitivity of peripheral blood lymphocytes to corticosteroids were measured before smoking cessation and at 6 wk. MAIN RESULTS Of 32 subjects recruited, 11 opted to continue smoking (smoking control group). Of 21 subjects who opted for smoking cessation, 10 quit smoking for 6 wk (quit group). In the comparison of quitters with smokers at 6 wk, the mean (confidence interval [CI]) difference in FEV(1) was 407 ml (21, 793), p = 0.040, and the proportion of sputum neutrophils was reduced by 29 (51, 8), p = 0.039. Total cutaneous vasoconstrictor response score to topical beclometasone improved after smoking cessation with a mean (CI) difference of 3.56 (0.84, 6.28), p = 0.042, between quitters and smokers. There was no change in airway corticosteroid responses after smoking cessation. CONCLUSIONS By 6 wk after smoking cessation, subjects who quit smoking had achieved considerable improvement in lung function and a fall in sputum neutrophil count compared with subjects who continued to smoke. These findings highlight the importance of smoking cessation in asthma.

[1]  P. Barnes.  Reduced histone deacetylase in COPD: clinical implications. , 2006, Chest.

[2]  D. Postma,et al.  Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers , 2005, European Respiratory Journal.

[3]  Thomas P. Erlinger,et al.  Smoking Cessation and Cardiovascular Disease Risk Factors: Results from the Third National Health and Nutrition Examination Survey , 2005, PLoS medicine.

[4]  Klas Svensson,et al.  Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. , 2005, Respiratory medicine.

[5]  N. Thomson,et al.  Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma , 2005, Thorax.

[6]  L. Boulet,et al.  Cigarette smoking and asthma: a dangerous mix. , 2005, Canadian respiratory journal.

[7]  Å. Westin,et al.  Effects of smoking cessation and reduction in asthmatics. , 2005, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[8]  N. Thomson,et al.  Asthma and cigarette smoking , 2004, European Respiratory Journal.

[9]  B. Rutgers,et al.  Smoking cessation improves both direct and indirect airway hyperresponsiveness in COPD , 2004, European Respiratory Journal.

[10]  K. J. Macleod,et al.  Interleukin‐18 levels in induced sputum are reduced in asthmatic and normal smokers , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[11]  I. Rahman,et al.  Macrophage phagocytosis of apoptotic neutrophils is compromised by matrix proteins modified by cigarette smoke and lipid peroxidation products. , 2004, Biochemical and biophysical research communications.

[12]  D. Postma,et al.  The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation , 2004, European Respiratory Journal.

[13]  N. Thomson,et al.  Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma. , 2003, American journal of respiratory and critical care medicine.

[14]  Edwin D Boudreaux,et al.  Cigarette smoking among asthmatic adults presenting to 64 emergency departments. , 2003, Chest.

[15]  R. Chazan,et al.  The cellular composition and macrophage phenotype in induced sputum in smokers and ex-smokers with COPD. , 2003, Chest.

[16]  Hiroshi Tanaka,et al.  Respiratory Symptoms and Cigarette Smoking in 3,197 Pulmonologist-Based Asthmatic Patients with a Highly Prevalent Use of Inhaled Corticosteroid , 2003, The Journal of asthma : official journal of the Association for the Care of Asthma.

[17]  R. Wilson,et al.  Effect of nicotine replacement and quitting smoking on circulating adhesion molecule profiles (sICAM‐1, sCD44v5, sCD44v6) , 2002, European journal of clinical investigation.

[18]  N. Chavannes,et al.  Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum. , 2002, American journal of respiratory and critical care medicine.

[19]  I. Pavord,et al.  Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids , 2002, Thorax.

[20]  D. Jacobs,et al.  Early life factors contribute to the decrease in lung function between ages 18 and 40: the Coronary Artery Risk Development in Young Adults study. , 2002, American journal of respiratory and critical care medicine.

[21]  K. J. Macleod,et al.  Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma , 2002, Thorax.

[22]  K. J. Macleod,et al.  Smoking and airway inflammation in patients with mild asthma. , 2001, Chest.

[23]  J. Bousquet,et al.  A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. , 2001 .

[24]  A. Matsuki,et al.  Recovery of Intraoperative Microbicidal and Inflammatory Functions of Alveolar Immune Cells after a Tobacco Smoke-free Period , 2001, Anesthesiology.

[25]  A. Wanner,et al.  Steroid sensitivity of norepinephrine uptake by human bronchial arterial and rabbit aortic smooth muscle cells. , 2001, American journal of respiratory cell and molecular biology.

[26]  V. Siroux,et al.  Relationships of active smoking to asthma and asthma severity in the EGEA study. Epidemiological study on the Genetics and Environment of Asthma. , 2000, The European respiratory journal.

[27]  C. Dayan,et al.  Wide variation in lymphocyte steroid sensitivity among healthy human volunteers. , 1999, The Journal of clinical endocrinology and metabolism.

[28]  G H Guyatt,et al.  Development and validation of a questionnaire to measure asthma control. , 1999, The European respiratory journal.

[29]  D. Prybylski,et al.  Cigarette smoking and asthma symptom severity among adult asthmatics. , 1999, The Journal of asthma : official journal of the Association for the Care of Asthma.

[30]  M. Pringle,et al.  Morbidity from asthma in relation to regular treatment: a community based study , 1999, Thorax.

[31]  A. Buist,et al.  Associations of smoking with hospital-based care and quality of life in patients with obstructive airway disease. , 1999, Chest.

[32]  J Vestbo,et al.  A 15-year follow-up study of ventilatory function in adults with asthma. , 1998, The New England journal of medicine.

[33]  S. Vedal,et al.  Risk factors for near-fatal asthma. A case-control study in hospitalized patients with asthma. , 1998, American journal of respiratory and critical care medicine.

[34]  M. Johnson,et al.  Development of fluticasone propionate and comparison with other inhaled corticosteroids. , 1998, The Journal of allergy and clinical immunology.

[35]  P. Barnes,et al.  Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force. , 1997, The European respiratory journal.

[36]  N. Santanello,et al.  Measurement characteristics of two asthma symptom diary scales for use in clinical trials. , 1997, The European respiratory journal.

[37]  W. Kuschner,et al.  Dose-dependent cigarette smoking-related inflammatory responses in healthy adults. , 1996, The European respiratory journal.

[38]  J. M. Cousin,et al.  Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. , 1996, Journal of immunology.

[39]  D. Webb,et al.  A comparison of techniques to assess skin blanching following the topical application of glucocorticoids , 1996, The British journal of dermatology.

[40]  L. Fabbri,et al.  Effect of smoking cessation on airway inflammation in chronic bronchitis. , 1995, American journal of respiratory and critical care medicine.

[41]  Todor A Popov,et al.  The evaluation of a cell dispersion method of sputum examination , 1994, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[42]  A. Miller,et al.  Guidelines for the evaluation of impairment/disability in patients with asthma. , 1994, American journal of respiratory and critical care medicine.

[43]  T. Peitz.  Long-term prognosis of near-fatal asthma , 1993 .

[44]  F. Saulnier,et al.  Long-term prognosis of near-fatal asthma. A 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for a near-fatal attack of asthma. , 1992, The American review of respiratory disease.

[45]  S. Szefler,et al.  Glucocorticoid resistance in chronic asthma. Glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro. , 1991, The American review of respiratory disease.

[46]  C. Edwards,et al.  Cutaneous vasoconstrictor response to glucocorticoids in asthma , 1991, The Lancet.

[47]  S. Rennard,et al.  Short-term smoking reduction is associated with reduction in measures of lower respiratory tract inflammation in heavy smokers. , 1990, The European respiratory journal.

[48]  P. Ebden,et al.  The effect of cigarette withdrawal on asthmatics who smoke. , 1987, European journal of respiratory diseases.

[49]  J. Saurat,et al.  RU 486 inhibits peripheral effects of glucocorticoids in humans. , 1985, The Journal of clinical endocrinology and metabolism.

[50]  R. Rylander,et al.  Asthma and cessation of smoking , 1984, Clinical allergy.

[51]  R. Stoughton,et al.  Method for Comparing Percutaneous Absorption of Steroids , 1962 .